Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Clinical trials news

Show

From To
Is It Safe to Interrupt HIV Treatment During Cure Studies?

Previous research has shown that long interruptions are not safe—but what about shorter, more closely monitored gaps in treatment?

Published
11 hours ago
From
POZ
HIV Vaccine Trials on Gay, Bi Men to Begin in U.S., Europe

Around 3800 men who have sex with men will be part of Johnson & Johnson's historic vaccine trial.

Published
15 July 2019
From
Advocate.com
EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database

The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database.

Published
07 July 2019
From
Health Policy Watch
Can Self-Swabs Make HIV Exposure and Risk Reporting More Accurate?

A new study conducted in South Africa finds that when cisgender women are given the tools to assess their HIV exposure risk at home, those tools can yield far more accurate results than a sit-down interview with an HIV clinician. The study also pioneered a new use case for swabbing kits, yielding valuable insights that lead author Maria Lemos, Ph.D., says may one day lead to a new method of self-testing for HIV exposure at home.

Published
01 July 2019
From
The Body Pro
Cases of hair loss among African-American women reported after switch to new tenofovir formula

Hair loss (alopecia) occurred in six African-American women living with HIV after switching to the new formula of tenofovir, clinicians report in Open Forum Infectious Diseases. The

Published
26 June 2019
By
Michael Carter
Breaking down HIV exclusions in cancer clinical trials

As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.

Published
10 June 2019
From
Fred Hutchinson Cancer Research Center
Half of H.I.V. Patients Are Women. Most Research Subjects Are Men.

Trials of vaccines and treatments have not included enough female participants. Now that scientists are exploring possible cures, the need to enroll women is greater than ever.

Published
31 May 2019
From
New York Times
UCSD has not told women with HIV of data breach, despite researchers' pleas

University of California San Diego officials stonewalled attempts to notify women in an HIV research study that their confidential data was breached more than seven months ago, an inewsource investigation has found. UCSD researchers conducting the EmPower Women study told university officials in October that participants’ names, audio-taped conversations and other sensitive materials were made accessible to everyone working at Christie’s Place, a San Diego nonprofit supporting women with HIV and AIDS.

Published
15 May 2019
From
inewsource
Analytical treatment interruptions: minimising the risks and maximising their scientific value

Recommendations for the safe and appropriate use of ‘analytical treatment interruptions’ have been developed by a group of HIV experts, including clinicians, patient advocates, bioethicists, social scientists and

Published
15 May 2019
By
Alain Volny-Anne
Despite Uptick, Black and Latinx People Have Relatively Low Participation in HIV Vaccine Trials

Black and Latinx people historically have not willfully participated in clinical trials in high numbers. Medical mistrust of research and health care institutions has long been a problem for conducting biomedical research. So what's causing the racial disparities in research participation, and what are researchers doing about it?

Published
14 May 2019
From
The Body Pro
← First12345...25Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.